NeuroPace

NeuroPace is dedicated to developing breakthrough technologies and advancing brain science to improve the quality of life for millions of people suffering from neurological disorders. The company's first product, the RNS System, is the only FDA-approved brain-responsive neurostimulator for the treatment of focal drug-resistant epilepsy. In addition to treating epilepsy, brain-responsive neuromodulation technology holds promise for treating other brain disorders that impact the quality of life for millions of patients worldwide.